← Leaderboards
Mark J. Mamula
Yale University
$14,388,770
Attributed
$15,577,132
Total exposure
14
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,577,132 · 14
By mechanism
R01$10,391,532 · 4
R42$2,508,722 · 2
P30$1,196,536 · 2
R41$776,350 · 4
P01$380,802 · 1
R21$323,190 · 1
Top collaborators
- Richard G Kibbey3 shared
- Kevan C Herold1 shared
Most similar at Yale University
Same institution · by research overlap
- Ann M Haberman$5,282,253
- Hester A Doyle$385,837
- John Peter Geibel$2,723,385
- Dejan P Zecevic$4,722,060
- Anthony N Van Den Pol$25,732,423
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsAutoantigensAutoimmunityAutoimmune DiseasesT-LymphocytePeptidesPathologyIn VivoB-LymphocytesSystemic Lupus ErythematosusBiologicalCellsResponseAutoimmune ResponsesTissuesImmunizationAutoreactive T CellAutoantibodiesAntibodiesImmunityLupusImmune ResponseLaboratoriesPeripheral
Grant awards (49)
Posttranslational Neoantigens in Autoimmunity and Metabolism in T1D$730,784
R01 · FY2025 · DK · contact PI
Posttranslational Neoantigens in Autoimmunity and Metabolism in T1D$730,784
R01 · FY2024 · DK · contact PI
Posttranslational Neoantigens in Autoimmunity and Metabolism in T1D$747,657
R01 · FY2023 · DK · contact PI
Multiplexed Bioassay for Checkpoint Inhibitor Autoimmunity$298,911
R41 · FY2020 · AI · contact PI
Post Translational Modifications in Tolerance and Autoimmunity$416,250
R01 · FY2019 · AI · contact PI
Post Translational Modifications in Tolerance and Autoimmunity$416,250
R01 · FY2018 · AI · contact PI
Autoimmunity to Protein Modifications in Checkpoint Inhibitor Induced and Spontaneous T1D$167,500
R01 · FY2018 · DK · contact PI
Post Translational Modifications in Tolerance and Autoimmunity$416,250
R01 · FY2017 · AI · contact PI
Post Translational Modifications in Tolerance and Autoimmunity$416,250
R01 · FY2016 · AI · contact PI
Post Translational Modifications in Tolerance and Autoimmunity$416,250
R01 · FY2015 · AI · contact PI
EGFR Peptides as Vaccines in Anti-Tumor Immunity$262,925
R42 · FY2013 · CA · contact PI
Post Translational Modifications in Tolerance and Autoimmunity$405,516
R01 · FY2012 · AI · contact PI
EGFR Peptides as Vaccines in Anti-Tumor Immunity$489,408
R42 · FY2011 · CA · contact PI
Post Translational Modifications in Tolerance and Autoimmunity$405,516
R01 · FY2011 · AI · contact PI
Molecular Mechanisms of Lymphocyte Interactions in Autoimmunity$298,272
R01 · FY2011 · AR · contact PI
In Vito Imaging$229,830
P30 · FY2011 · AR · contact PI
Mechanisms of Antigen Trafficking in Autoimmunity$26,979
P30 · FY2011 · AR · contact PI
EGFR Peptides as Vaccines in Anti-Tumor Immunity$628,721
R42 · FY2010 · CA · contact PI
Post Translational Modifications in Tolerance and Autoimmunity$409,613
R01 · FY2010 · AI · contact PI
Molecular Mechanisms of Lymphocyte Interactions in Autoimmunity$310,700
R01 · FY2010 · AR · contact PI
In Vito Imaging$225,902
P30 · FY2010 · AR · contact PI
Mechanisms of Antigen Trafficking in Autoimmunity$31,183
P30 · FY2010 · AR · contact PI
Post Translational Modifications in Tolerance and Autoimmunity$413,750
R01 · FY2009 · AI · contact PI
Molecular Mechanisms of Lymphocyte Interactions in Autoimmunity$313,838
R01 · FY2009 · AR · contact PI
In Vito Imaging$225,880
P30 · FY2009 · AR · contact PI
Mechanisms of Antigen Trafficking in Autoimmunity$32,202
P30 · FY2009 · AR · contact PI
Post Translational Modifications in Tolerance and Autoimmunity$413,438
R01 · FY2008 · AI · contact PI
Molecular Mechanisms of Lymphocyte Interactions in Autoimmunity$313,838
R01 · FY2008 · AR · contact PI
In Vito Imaging$199,205
P30 · FY2008 · AR · contact PI
Mechanisms of Antigen Trafficking in Autoimmunity$52,239
P30 · FY2008 · AR · contact PI
Modified HER-2 Tumor Antigens for Vaccination in Cancer$574,787
R42 · FY2007 · CA · contact PI
Molecular Mechanisms of Lymphocyte Interactions in Autoimmunity$319,275
R01 · FY2007 · AR · contact PI
EGFR Peptides as Vaccines in Anti-Tumor Immunity$277,711
R41 · FY2007 · CA · contact PI
In Vito Imaging$131,845
P30 · FY2007 · AR · contact PI
Mechanisms of Antigen Trafficking in Autoimmunity$41,271
P30 · FY2007 · AR · contact PI
Modified HER-2 Tumor Antigens for Vaccination in Cancer$552,881
R42 · FY2006 · CA · contact PI
Post Translational Modifications and Autoimmunity$327,000
R01 · FY2005 · AI
Post Translational Modifications and Autoimmunity$327,000
R01 · FY2004 · AI
Modified HER-2 Tumor Antigens for Vaccination in Cancer$99,899
R41 · FY2004 · CA
Isoaspartyl Modified Tumor Antigens for Vaccination$99,829
R41 · FY2004 · CA
Post Translational Modifications and Autoimmunity$327,000
R01 · FY2003 · AI
Post Translational Modifications and Autoimmunity$327,000
R01 · FY2002 · AI
MOLECULAR MECHANISMS OF LYMPHOCYTE INTERACTIONS IN SLE$214,731
R01 · FY2002 · AR
MOLECULAR MECHANISMS OF LYMPHOCYTE INTERACTIONS IN SLE$312,713
R01 · FY2001 · AR
ROLE OF SELF PEPTIDES IN TOLERANCE AND AUTOIMMUNITY$247,465
P01 · FY2001 · AI
Post Translational Modifications and Autoimmunity$190,751
R01 · FY2001 · AI
POST TRANSLATIONAL MODIFICATIONS AND AUTOIMMUNITY$323,190
R21 · FY2000 · AI
MOLECULAR MECHANISMS OF LYMPHOCYTE INTERACTIONS IN SLE$303,606
R01 · FY2000 · AR
ROLE OF SELF PEPTIDES IN TOLERANCE AND AUTOIMMUNITY$133,337
P01 · FY2000 · AI